Powered by Google-Search & Google-Books Chinese Standards Shop Database: 169760 (Oct 17, 2020)
HOME   Quotation   Tax   Examples Standard-List   Contact-Us   View-Cart
  

YY/T 1233-2014

Chinese Standard: 'YY/T 1233-2014'
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusRelated Standard
YY/T 1233-2014English140 Add to Cart 0--10 minutes. Auto immediate delivery. Cardiac troponin-I (cTnl) quantitative detection reagent (kit) (Chemiluminescent immunoassay) Valid YY/T 1233-2014
YY/T 1233-2014Chinese14 Add to Cart <=1-day [PDF from Chinese Authority, or Standard Committee, or Publishing House]

  In 0~10 minutes time, full copy of this English-PDF will be auto-immediately delivered to your email. See samples for translation quality.  

BASIC DATA
Standard ID YY/T 1233-2014 (YY/T1233-2014)
Description (Translated English) Cardiac troponin-I (cTnl) quantitative detection reagent (kit) (Chemiluminescent immunoassay)
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C44
Classification of International Standard 11.100
Word Count Estimation 8,825
Date of Issue 2014/6/17
Date of Implementation 2015/7/1
Quoted Standard GB/T 21415
Drafting Organization Beijing Medical Device Testing
Administrative Organization National medical clinical testing laboratory and in vitro diagnostic systems Standardization Technical Committee
Regulation (derived from) China Food and Drug Administration in 2014 Bulletin No. 30
Proposing organization State Food and Drug Administration
Issuing agency(ies) State Food and Drug Administration
Summary This Standard applies to human cardiac troponin -I (cTnI) reagent (box) quantitative determination principle to CLIA law, including microplates, tubes, magnetic particles as carrier enzymatic and non-enzymatic chemiluminescence immunoassay assay reagent (

YY/T 1233-2014
YY
ICS 11.100
C 44
Pharmaceutical Industry Standard
of the People’s Republic of China
Cardiac troponin-I (cTnI)
quantitative detection reagent (kit)
(Chemiluminescent immunoassay)
心肌肌钙蛋白-I 定量测定试剂(盒) (化学发光免疫分析法)
ISSUED ON. JUNE 17, 2014
IMPLEMENTED ON. JULY 1, 2015
Issued by. State Food and Drug Administration
Table of Contents
Foreword ... 3 
1 Scope ... 4 
2 Normative references ... 4 
3 Terms and definitions ... 4 
4 Requirements ... 5 
5 Test methods ... 6 
6 Marks, labels and instructions ... 9 
7 Packaging, transportation and storage ... 11 
Foreword
This Standard was drafted according to the rules given by GB/T 1.1-2009.
Please note that some contents of this Document may involve patents. The issuing
authority of this Document does not undertake the responsibility for the identification
of these patents.
This Standard was proposed by State Food and Drug Administration.
This Standard shall be under the jurisdiction of the Standardization Technical
Committee of National Medical Clinical Test Laboratory and in Vitro Diagnostic
System (SAC/TC 136).
Main drafting organizations of this Standard. Beijing Institute of Medical Device
Testing, Zhengzhou Auto Biological Engineering Co., Ltd., Beckman Coulter Trading
(China) Co., Ltd., Roche Diagnostic Products (Shanghai) Co., Ltd., Abbott Trading
(Shanghai) Co., Ltd., and Johnson & Johnson (Shanghai) Medical Equipment Co.,
Ltd.
Main drafters of this Standard. Wang Ruixia, Li Xiaoxia, Zhang Jinwen, Du Haiou, Liu
Rong, Wang Xuefeng, and Qi Xin.
Cardiac troponin-I (cTnI)
quantitative detection reagent (kit)
(Chemiluminescent immunoassay)
1 Scope 
This Standard specifies the terms and definitions, requirements, test methods,
marking, labeling, instructions, packaging, transportation, and storage of cardiac
troponin-I (cTnI) quantitative detection reagent (kit) (chemiluminescent
immunoassay).
This Standard applies to the quantitative detection of human cardiac troponin-I (cTnI)
quantitative detection reagent (kit) [hereinafter referred to as "cTnI reagent (kit)"] by
the principal of chemiluminescent immunoassay, including the enzymatic and
non-enzymatic chemiluminescent immunoassay detection reagent (kit) with carriers
such as microplates, tubes, and magnetic particles.
This Standard does not apply to the requirements for the calibrator and control
materials in reagent (kit).
2 Normative references 
The following document is essential for the application of this Document. For dated
references, only dated versions apply to this Document. For undated references, the
latest version (excluding corrections) applies to this Document.
GB/T 21415 In vitro diagnostic medical devices - Measurement of quantities in
biological samples - Metrological traceability of values assigned to calibrator and
control materials
3 Terms and definitions 
The following terms and definitions apply to this Document.
3.1
limit of blank; LOB
In claimed probability, the highest measurement result of blank sample that can be
observed.
[NCCLS, EP17]
4 Requirements 
4.1 Appearance
Appearance shall meet the following requirements.
a) Each component of reagent (kit) shall be complete, intact, and no leakage of
liquid;
b) Chinese packaging labels shall be clear, without wear and tear.
4.2 Traceability
Manufacturing enterprise shall provide the contents such as source, traceable
assignment process, corresponding requirements, and uncertainty of the cTnI
calibrator used, according to GB/T 21415 and the relevant provisions.
4.3 Accuracy
Accuracy shall meet one of the following requirements.
a) USE reference material as the sample to perform detection. The relative
deviation of measurement results shall be within the interval of ± 20%.
b) ADD the cardiac troponin-I (cTnI) of known concentration INTO the blood matrix
or other body fluid components. The recovery rate shall be within the interval
(85%~115%).
4.4 Blank limit
It shall meet the requirements of the manufacturer, and not higher than the upper limit
of the reference interval of normal people.
4.5 Linear interval
The upper limit of linear interval shall not be lower than 25ng/mL; the lower limit shall
be lower than the reference interval of normal people. Within the linear interval
specified by manufacturing enterprise, the correlation coefficient of reagent kit |r| shall
be ≥0.990.
4.6 Repeatability
USE the sample of which the critical value of acute myocardial infarction is at ± 50%
level, to test repeatedly for 10 times. Its coefficient of variation (CV) shall not exceed
10% (instrument automatic operation method) or not more than 15% (manual
operation method).
r) Manufacturing enterprise;
s) ......
Related standard:   YY/T 1223-2014  YY/T 1224-2014
Related PDF sample:   YY/T 1235-2014  YY/T 1240-2014
   
 
Privacy   ···   Product Quality   ···   About Us   ···   Refund Policy   ···   Fair Trading   ···   Quick Response
Field Test Asia Limited | Taxed in Singapore: 201302277C | Copyright 2012-2020